ArticleDigestive diseases and sciences2020

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.

Robin D Tucker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.